# Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women

> **NCT07635082** · PHASE2 · COMPLETED · sponsor: **Eman Basuni Ebrahim Mowad** · enrollment: 200 (actual)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS) Women
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** ELP (Extended Letrozole Protocol)
- **DRUG:** LIP (Letrozole + Inositol Protocol)

## Key facts

- **NCT ID:** NCT07635082
- **Lead sponsor:** Eman Basuni Ebrahim Mowad
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635082, "Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*